42 CFR Subpart I
Payment for Drugs
June 11, 2020
§
447.500
Basis and purpose
§
447.502
Definitions
§
447.504
Determination of average manufacturer price
§
447.505
Determination of best price
§
447.506
Authorized generic drugs
§
447.507
Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs)
§
447.508
Exclusion from best price of certain sales at a nominal price
§
447.509
Medicaid drug rebates (MDR)
§
447.510
Requirements for manufacturers
§
447.511
Requirements for States
§
447.512
Drugs: Aggregate upper limits of payment
§
447.514
Upper limits for multiple source drugs
§
447.516
Upper limits for drugs furnished as part of services
§
447.518
State plan requirements, findings, and assurances
§
447.520
Federal Financial Participation (FFP): Conditions relating to physician-administered drugs
§
447.522
Optional coverage of investigational drugs and other drugs not subject to rebate